Measles sero-surveillance during mass immunisation campaign in Malawi. 2001

M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
Community Health Sciences Unit, Ministry of Health and Population, Private Bag 65, Lilongwe, Malawi.

OBJECTIVE To determine age-specific measles antibody prevalence and serological response to vaccination during the first mass campaign against measles in Malawi. METHODS Cross-sectional study using a questionnaire and a serological particle agglutination (PA) test. METHODS Two health centres in Salima district, central Malawi during the national measles immunisation week, 1998. METHODS Two hundred forty six under-five year old children. RESULTS Seventy four per cent of enrolled children (95% confidence interval, 69-80%) were measles PA antibody positive at the vaccination. The antibody positive rate was 17.4% in children aged 8-12 months and gradually increased up to 90% by four years-old, while the age-specific geometric mean titers (GMTs) in 48-59 months-old group were significantly lower than those in 24-35 months-old group, suggesting antibody waning after previous vaccination (p = 0.0047). Two hundred and thirty follow up specimens were obtained eight weeks after the vaccination. The sero-conversion rate was 100% in 58 children sero-negative at the vaccination and the GMTs in 172 children seropositive at the vaccination were significantly increased (p < 0.001). CONCLUSIONS These results indicated that the first national measles immunisation campaign successfully immunised the enrolled children or gave a booster response of antibody levels. It was also confirmed that the PA test was easy to perform and most suitable for the field condition in developing countries.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007223 Infant A child between 1 and 23 months of age. Infants
D008295 Malawi A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland. Nyasaland,Republic of Malawi
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
August 1994, Communicable disease report. CDR weekly,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
January 1996, Health bulletin,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
May 1995, Releve epidemiologique hebdomadaire,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
October 1994, BMJ (Clinical research ed.),
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
September 1995, The Journal of communicable diseases,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
July 1995, BMJ (Clinical research ed.),
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
August 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
July 1998, Communicable diseases intelligence,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
May 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M Takechi, and M Matsuo, and D Butao, and I L Zungu, and I Chakanika, and J Michongwe
October 1994, BMJ (Clinical research ed.),
Copied contents to your clipboard!